Hsbc Holdings PLC Has $16.95 Million Holdings in STERIS plc (NYSE:STE)

Hsbc Holdings PLC lifted its holdings in STERIS plc (NYSE:STE - Free Report) by 93.4% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 82,604 shares of the medical equipment provider's stock after purchasing an additional 39,894 shares during the period. Hsbc Holdings PLC owned about 0.08% of STERIS worth $16,946,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also made changes to their positions in the business. OneDigital Investment Advisors LLC increased its holdings in shares of STERIS by 3.2% in the fourth quarter. OneDigital Investment Advisors LLC now owns 22,431 shares of the medical equipment provider's stock valued at $4,611,000 after buying an additional 704 shares in the last quarter. Tower Research Capital LLC TRC grew its holdings in shares of STERIS by 198.4% in the 4th quarter. Tower Research Capital LLC TRC now owns 6,538 shares of the medical equipment provider's stock worth $1,344,000 after acquiring an additional 4,347 shares during the last quarter. Kayne Anderson Rudnick Investment Management LLC grew its holdings in shares of STERIS by 8.2% in the 4th quarter. Kayne Anderson Rudnick Investment Management LLC now owns 95,615 shares of the medical equipment provider's stock worth $19,655,000 after acquiring an additional 7,285 shares during the last quarter. MetLife Investment Management LLC raised its position in shares of STERIS by 1.9% during the fourth quarter. MetLife Investment Management LLC now owns 26,121 shares of the medical equipment provider's stock worth $5,369,000 after purchasing an additional 480 shares during the period. Finally, Norinchukin Bank The lifted its holdings in shares of STERIS by 12.3% during the fourth quarter. Norinchukin Bank The now owns 105,868 shares of the medical equipment provider's stock valued at $21,762,000 after purchasing an additional 11,624 shares during the last quarter. 94.69% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on STE. Stephens reissued an "overweight" rating and issued a $240.00 price target on shares of STERIS in a research note on Thursday, February 6th. Piper Sandler lifted their target price on shares of STERIS from $260.00 to $265.00 and gave the stock an "overweight" rating in a research report on Monday, February 3rd. JMP Securities restated a "market outperform" rating and issued a $265.00 price target on shares of STERIS in a research report on Thursday, April 10th. Finally, Needham & Company LLC reaffirmed a "hold" rating on shares of STERIS in a research note on Monday, April 7th. One analyst has rated the stock with a hold rating and five have given a buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $258.75.

STERIS Stock Down 1.1 %

Shares of STE traded down $2.41 during trading hours on Thursday, reaching $222.33. The company's stock had a trading volume of 1,084,206 shares, compared to its average volume of 536,137. The company has a 50 day moving average of $223.12 and a two-hundred day moving average of $218.91. The company has a quick ratio of 1.40, a current ratio of 2.13 and a debt-to-equity ratio of 0.32. The firm has a market cap of $21.84 billion, a price-to-earnings ratio of 47.20 and a beta of 0.87. STERIS plc has a 1-year low of $200.98 and a 1-year high of $248.24.

STERIS (NYSE:STE - Get Free Report) last released its quarterly earnings data on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $2.33 by ($0.01). STERIS had a net margin of 8.66% and a return on equity of 13.91%. As a group, research analysts predict that STERIS plc will post 9.08 EPS for the current fiscal year.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.